The Crispr Baby Scientist Is Back. Here’s What He’s Doing Next
By Emily Mullin,
Wired
| 12. 21. 2022
In November 2018, Chinese scientist He Jiankui shocked the world when he announced, first on YouTube and then at an international scientific gathering in Hong Kong, that he had used Crispr to alter the genetic makeup of human embryos, which were used to establish pregnancies and resulted in the birth of the world’s first gene-edited babies.
Backlash against He was harsh and swift. Members of the scientific community condemned his experiments as unethical and voiced concerns over the babies’ health, about which little is known today. The Chinese government suspended his research, saying he violated medical regulations. In December 2019, a Chinese court found He guilty of illegal medical practices and sentenced him to three years' imprisonment. In light of He’s experiment, China has since adopted regulations prohibiting the modification of human embryos for reproductive purposes. He was released from prison in April.
In recent months, He has taken to Twitter and the Chinese social media platform Weibo to publicize his next steps. Previously a researcher at Southern University of Science and Technology in Shenzhen, He says...
Related Articles
By Abby Vesoulis, Mother Jones | 04.18.2026
Two years ago, we devoted an entire issue to the rise of the American oligarchy. Since then, our oligarchic system has become more entrenched and pervasive, revolving around a small crew of tech titans whose quest for wealth and...
By Miguel Muñoz, Cadena SER [cites Marcy Darnovsky] | 08.04.2026
"Para ellos, una familia numerosa no solo es una preferencia personal, sino que es una obligación. Creen que tener tantos hijos como sea posible es necesario para evitar un futuro apocalíptico", aseguraba Xavier Orri, periodista y cofundador de Página Internacional...
By Ryan Cross, Endpoints News | 03.24.2026
Cathy Tie has an audacity more typical of a tech startup founder than a biotech executive. She dropped out of college to start a genetic screening company and later founded a telemedicine startup. The 29-year-old has been on two Forbes...
By Alex Polyakov, The Conversation | 02.09.2026
Prospective parents are being marketed genetic tests that claim to predict which IVF embryo will grow into the tallest, smartest or healthiest child.
But these tests cannot deliver what they promise. The benefits are likely minimal, while the risks to...